| Brand name | Bagui 3.5 mg |
|---|---|
| Generic name | Bortezomib |
| Packaging type | Vial |
| Molecule | Bortezomib 3.5 mg |
| Form | Injection |
| Marketed By | Glarea Healthcare |
| Dose | 3.5 mg |
$103.00
Send EnquiryGeneric Bortezomib 3.5 mg injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. It shows its working by stopping or slowing down the growth of cancer cells. Your doctor will decide what dose is necessary and how often you need to take it. Taking it in the wrong way or taking too much can cause severe side effects.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Bortezomib 3.5 mg Injection is an anti-cancer medication. It works by blocking or slowing the breakdown of proteins in cells. As a result, there is an increase in the number of proteins in the cancer cells, leading to death.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
It is essential to get each Bortezomib dose of this medication as scheduled. If you miss a Bortezomib dose, ask your doctor or pharmacist right away for a new dosing schedule.
Not applicable. This medication is given in a clinic and will not be stored at home.
Yes. The FDA has approved Bortezomib for people with newly diagnosed as well as relapsed multiple myeloma, including people who previously received Bortezomib. Talk with your doctor or healthcare team about whether Bortezomib may be right for you.
Your treatment schedule will vary depending on your diagnosis and treatment regimen.
